Ekso Bionics
Ekso Bionics is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Ekso Bionics.
Ekso Bionics is a company.
Key people at Ekso Bionics.
Ekso Bionics is a pioneering exoskeleton company that develops wearable robotic devices to enhance human mobility, primarily serving medical rehabilitation for patients with paralysis or spinal cord injuries and industrial workers needing strength augmentation.[1][4][7] Its key products include EksoNR and EksoGT for gait training in rehab settings, allowing users to stand and walk, and EksoUE and EksoVest for industrial load-bearing tasks.[1][2][3] The company solves critical problems like relearning to walk post-injury and reducing workplace musculoskeletal risks, with growth momentum shown through expansions into hospitals since 2015, product launches like EksoUE in 2020, and recent marketing-driven increases in conversions by 166.7% and organic visitors by 28.8%.[1][5]
Headquartered in Richmond, California (now with operations in San Rafael), Ekso Bionics went public in 2014 (NASDAQ: EKSO) and focuses on health and industrial sectors, emphasizing robotics to restore function and amplify abilities.[1][3][4][7]
Ekso Bionics originated in 2005 as Berkeley ExoWorks, founded by Homayoon Kazerooni, Russ Angold, and Nathan Harding from the University of California, Berkeley's Robotics and Human Engineering Laboratory.[1][2][3] The idea emerged from academic research into exoskeletons, starting with prototypes like ExoHiker and ExoClimber, which enabled able-bodied users to carry 150 pounds effortlessly.[1][2]
Renamed Berkeley Bionics in 2007, it advanced to the HULC (Human Universal Load Carrier), a hydraulic exoskeleton licensed to Lockheed Martin in 2009 for military use, marking early traction.[1][2][3] Pivoting to medical applications, it debuted eLEGS (later EksoGT) in 2011 for wheelchair users, with clinical testing in U.S. and European rehab centers.[1][2] The company renamed to Ekso Bionics, went public in 2014 amid funding challenges, and expanded into industrial products in 2015 while nearly closing in 2013 before securing government contracts.[1][3] Key moments include adding Variable Assist software in 2013 for adaptive power and launching EksoUE in 2020.[1]
Ekso Bionics stands out in the exoskeleton market through its broad expertise across medical, industrial, military, and research applications, developed over nearly two decades.[3][4][7]
Ekso Bionics rides the wave of wearable robotics and human augmentation, a trend exploding with aging populations, rising spinal injury rates (e.g., 250,000+ U.S. cases annually), and industrial demands for injury prevention amid labor shortages.[4][7] Timing aligns with FDA approvals for rehab exoskeletons since the 2010s and growing industrial adoption to cut workers' comp costs, positioning Ekso ahead of peers like ReWalk or Cyberdyne.[3]
Market forces favor it: healthcare robotics market projected to grow rapidly, with exoskeletons addressing rehab inefficiencies (e.g., faster walking recovery); industrial segment taps ergonomics regulations and e-commerce-driven logistics strain.[1][5][7] Ekso influences the ecosystem by pioneering civilian-to-military tech transfer, enabling R&D for global partners, and normalizing exoskeletons in hospitals and factories, fostering broader robotics innovation.[2][4]
Ekso Bionics is poised for expansion with maturing products like EksoNR in rehab and EksoVest in industry, potentially targeting at-home devices and upper-body worker aids amid rising telehealth and automation trends.[2][7] Leadership under CEO Scott Davis (since 2022) emphasizes scalability and partnerships, building on recent digital marketing wins.[4]
Shaping factors include AI-enhanced adaptive controls, insurance reimbursements for rehab, and industrial IoT integration for real-time ergonomics data. Its influence may evolve from niche pioneer to market leader if it narrows focus post-broad experimentation, driving human-robot symbiosis in health and work—echoing its founding mission to amplify natural abilities where biology falls short.[1][4][7]
Key people at Ekso Bionics.
